https://pharmadog.xyz/news/344298 pharmadog en 2026-08-30T17:29:05.000Z Alnylam defends its heart failure silencers after AstraZeneca's ATTR-CM trial miss https://pharmadog.xyz/news/343987 pharmadog en 2026-08-30T15:40:30.000Z Arrowhead's RNAi drug Redemplo shows safety advantage over Ionis in late-stage triglyceride trials https://pharmadog.xyz/news/342718 pharmadog en 2026-08-30T07:19:28.000Z AstraZeneca’s oral relaxin drug shows partial success in mid-stage heart-failure trial https://pharmadog.xyz/news/339043 pharmadog en 2026-08-29T10:00:51.000Z FDA grants approval to Revolution Medicines' Rasonque for pancreatic cancer https://pharmadog.xyz/news/338831 pharmadog en 2026-08-29T07:32:11.000Z Novartis IL-6 antibody pacibekitug cuts inflammation markers in Phase 2 study https://pharmadog.xyz/news/338659 pharmadog en 2026-08-29T06:55:35.000Z Novartis launches Phase 3 trial of IL-6 antibody to test cardiovascular benefit despite Novo's setback https://pharmadog.xyz/news/340201 pharmadog en 2026-08-29T00:23:00.000Z Northwest Naturals recalls frozen cat and dog chicken diets over possible Salmonella and Listeria contamination https://pharmadog.xyz/news/337447 pharmadog en 2026-08-28T22:15:30.000Z FDA greenlights Takeda and Protagonist's rusfertide (Mimrylo) for polycythemia vera https://pharmadog.xyz/news/337303 pharmadog en 2026-08-28T21:22:41.000Z FDA approves Mimrylo, first hepcidin-mimicking drug for polycythemia vera https://pharmadog.xyz/news/336959 pharmadog en 2026-08-28T19:51:56.000Z Juul receives FDA clearance for new e-cigarette with optional age-verification feature